Myocardial performance index in fetuses with small-for-gestational age in pregnancy: a systematic review and meta-analysis
Open Access
- 11 November 2025
- journal article
- review article
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-12
Abstract
The clinical utility and consistency of fetal Myocardial Performance Index (MPI) in assessing small for gestational age (SGA) remains contentious. Therefore, this study aimed to systematically evaluate the association between fetal MPI and SGA, and to assess the predictive value of MPI for adverse perinatal outcomes. PubMed, EMBASE, Web of Science, and The Cochrane Library were searched up to January 13, 2025. Studies comparing fetal MPI in singleton SGA pregnancies with healthy controls were included. Reviews, case reports, and studies without a control group were excluded. Data extraction followed PRISMA guidelines, and the protocol was prospectively registered with PROSPERO (CRD42023482293). Pooled estimates were generated using random-effects models for MPI and fixed-effects models for adverse perinatal outcomes. Subgroup, sensitivity, and meta-regression analyses were conducted. 35 studies were included in the systematic review, with 27 eligible for meta-analysis. Fetuses with SGA had a significantly higher mean left fetal MPI compared to controls (WMD, 0.09; 95% CI, 0.06–0.11; I²=97%, P < 0.001). Subgroup analysis according to the classification of SGA revealed significant subgroup differences (P < 0.01), which remained consistent across SGA subtypes. No marked differences were found in gestational age at ultrasound and echocardiography technique. Elevated MPI was associated with an increased risk of adverse perinatal outcomes (OR, 3.71; 95% CI, 2.49–5.52; I²=0%, P < 0.001). This meta-analysis demonstrates that fetal MPI is significantly elevated in SGA pregnancies, indicating impaired global ventricular function. An increased MPI is associated with a higher risk of adverse perinatal outcomes. These findings support the potential utility of MPI as a tool for monitoring and risk stratification in SGA pregnancies. Not applicable.Keywords
This publication has 54 references indexed in Scilit:
- Fetal epicardial fat thickness and modified myocardial performance index in late‐onset fetal growth restrictionJournal of Clinical Ultrasound, 2024
- Ductus arteriosus diameters in fetuses with early‐ and late‐onset fetal growth restrictionJournal of Clinical Ultrasound, 2024
- Assessment of fetal cardiac morphology and functional changes in early‐onset and late‐onset fetal growth restrictionInternational Journal of Gynecology & Obstetrics, 2022
- FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restrictionInternational Journal of Gynecology & Obstetrics, 2021
- Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2020
- Perinatal changes in cardiac geometry and function in growth‐restricted fetuses at termUltrasound in Obstetrics & Gynecology, 2019
- Fetal myocardial performance index in assessment and management of small‐for‐gestational‐age fetus: a cohort and nested case–control studyUltrasound in Obstetrics & Gynecology, 2018
- Fetal cardiac function in late-onset intrauterine growth restrictionvssmall-for-gestational age, as defined by estimated fetal weight, cerebroplacental ratio and uterine artery DopplerUltrasound in Obstetrics & Gynecology, 2015
- Risk of ultrasound-detected neonatal brain abnormalities in intrauterine growth-restricted fetuses born between 28 and 34 weeks' gestation: relationship with gestational age at birth and fetal Doppler parametersUltrasound in Obstetrics & Gynecology, 2015
- Determination of the myocardial performance index in deteriorating grades of intrauterine growth restriction and its link to adverse outcomesPrenatal Diagnosis, 2014